U.S. flag

An official website of the United States government

NM_000075.4(CDK4):c.647G>A (p.Gly216Glu) AND Familial melanoma

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 5, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001864628.4

Allele description [Variation Report for NM_000075.4(CDK4):c.647G>A (p.Gly216Glu)]

NM_000075.4(CDK4):c.647G>A (p.Gly216Glu)

Genes:
CDK4:cyclin dependent kinase 4 [Gene - OMIM - HGNC]
TSPAN31:tetraspanin 31 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q14.1
Genomic location:
Preferred name:
NM_000075.4(CDK4):c.647G>A (p.Gly216Glu)
HGVS:
  • NC_000012.12:g.57749490C>T
  • NG_007484.2:g.7892G>A
  • NM_000075.4:c.647G>AMANE SELECT
  • NM_001330168.2:c.*2200C>T
  • NM_001330169.2:c.*2200C>T
  • NM_005981.5:c.*2200C>TMANE SELECT
  • NP_000066.1:p.Gly216Glu
  • NP_000066.1:p.Gly216Glu
  • LRG_490t1:c.647G>A
  • LRG_490:g.7892G>A
  • LRG_490p1:p.Gly216Glu
  • NC_000012.11:g.58143273C>T
  • NM_000075.2:c.647G>A
Protein change:
G216E
Links:
dbSNP: rs1955206366
NCBI 1000 Genomes Browser:
rs1955206366
Molecular consequence:
  • NM_001330168.2:c.*2200C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001330169.2:c.*2200C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_005981.5:c.*2200C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_000075.4:c.647G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial melanoma
Synonyms:
Hereditary melanoma; Hereditary cutaneous melanoma
Identifiers:
MONDO: MONDO:0018961; MedGen: C1512419

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002141730Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 5, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002141730.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 216 of the CDK4 protein (p.Gly216Glu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CDK4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1371732). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CDK4 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024